The most striking finding is JBGS's three‑month outperformance (+0.5% vs. -9.1% for the S&P), which signals that recent lease renewals or cost‑control measures are beginning to translate into shareholder value, making the stock a potential defensive play in a still‑volatile environment.
Investors should watch the lingering negative five‑year annualized return of -11.6%; if interest rates remain elevated, higher borrowing costs could erode net operating income and re‑ignite the downward trajectory, potentially widening the performance gap with peers.
The -13.29% institutional outflow translates to roughly $150 million withdrawn (based on current market cap), which could accelerate price declines if the selling pressure continues, especially given the already elevated volatility and negative Sharpe ratio.
The simultaneous double‑digit revenue drop and negative EPS highlight a deteriorating earnings power that threatens dividend sustainability and raises questions about the firm’s ability to fund future development without external capital.
The net margin deficit of 27.9% translates into an annual cash outflow of roughly $138 M (499 M × 27.9%), a scale that could trigger covenant breaches if debt levels rise or refinancing conditions tighten.
The transition to a -27.9% profit margin is the pivotal driver of the -12.0% ROE, underscoring that core operating performance has turned deeply unprofitable rather than being a purely balance‑sheet effect.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -12.0 | -27.9 | 0.11 | 3.79 | -7.4 | -0.2 | -3.2 |
| 2024 | -7.9 | -26.2 | 0.11 | 2.78 | 2.3 | 0.1 | -2.9 |
| 2023 | -3.6 | -13.2 | 0.11 | 2.48 | 13.3 | 0.9 | -1.4 |
| 2022 | 3.2 | 14.1 | 0.10 | 2.20 | 5.2 | 0.4 | 1.4 |
| 2021 | -2.7 | -12.5 | 0.10 | 2.19 | -0.1 | -0.0 | -1.2 |
| 2020 | -1.9 | -10.3 | 0.10 | 1.90 | 0.0 | 0.0 | -1.0 |
| 2019 | 1.9 | 10.1 | 0.11 | 1.77 | 204.4 | 4.2 | 1.1 |
| 2018 | 1.3 | 6.2 | 0.11 | 2.01 | 1.0 | 0.9 | 0.7 |
| 2017 | -2.4 | -13.2 | 0.09 | 2.04 | -0.9 | -0.9 | -1.2 |
| 2016 | 2.9 | 13.0 | 0.13 | 1.73 | 3.5 | 3.4 | 1.7 |
| 2015 | 2.2 | 9.8 | 0.13 | 1.72 | 3.1 | 2.9 | 1.3 |
The 96‑day cash conversion cycle represents a $120 million drag on cash flow (assuming average daily operating expenses of $1.25 million), heightening refinancing risk if earnings do not rebound.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 3212 | 0 | 150 | 30 | 54 | 96 |
| 2024 | 3348 | 0 | 129 | 29 | 135 | -6 |
| 2023 | 3334 | 0 | 130 | 36 | 157 | -27 |
| 2022 | 3557 | 0 | 137 | 1 | 164 | -27 |
| 2021 | 3675 | 0 | 136 | 105 | 118 | 18 |
| 2020 | 3682 | 0 | 137 | 28 | 114 | 24 |
| 2019 | 3380 | 0 | 126 | 11 | 179 | -53 |
| 2018 | 3398 | 0 | 108 | 2686 | 155 | -47 |
| 2017 | 4081 | 24 | 130 | 3364 | 221 | -66 |
| 2016 | 2792 | 0 | 187 | 2460 | 86 | 101 |
| 2015 | 2812 | 0 | 121 | 2427 | 112 | 9 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $4388M | $2719M | $1158M | $2543M | $2468M | $75M | $318M | $303M |
| 2024 | $5021M | $2788M | $1809M | $2618M | $2473M | $146M | $388M | $205M |
| 2023 | $5519M | $2826M | $2223M | $2638M | $2473M | $165M | $429M | $187M |
| 2022 | $5903M | $2708M | $2682M | $2464M | $2223M | $241M | $518M | $168M |
| 2021 | $6386M | $2925M | $2916M | $2681M | $2416M | $264M | $558M | $439M |
| 2020 | $6080M | $2343M | $3206M | $2077M | $1851M | $226M | $532M | $137M |
| 2019 | $5986M | $1987M | $3386M | $1702M | $1576M | $126M | $381M | $358M |
| 2018 | $5997M | $2452M | $2987M | $2136M | $1875M | $261M | $590M | $135M |
| 2017 | $6072M | $2488M | $2971M | $2204M | $1887M | $317M | $555M | $139M |
| 2016 | $3661M | $1539M | $2122M | $1165M | $1136M | $29M | $277M | $324M |
| 2015 | $3625M | $1516M | $2108M | $1303M | $1228M | $75M | $311M | $137M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $73M | $357M | $-510M | $-122M | $-49M | $-444M | $-48M |
| 2024 | $129M | $144M | $-291M | $-218M | $-89M | $-171M | $-62M |
| 2023 | $183M | $-98M | $-159M | $-334M | $-150M | $-335M | $-94M |
| 2022 | $178M | $524M | $-730M | $-327M | $-149M | $-361M | $-108M |
| 2021 | $218M | $-369M | $190M | $-173M | $44M | $-158M | $-118M |
| 2020 | $169M | $-168M | $119M | $-307M | $-138M | $-105M | $-120M |
| 2019 | $174M | $-241M | $-190M | $-441M | $-267M | $-130M | |
| 2018 | $188M | $66M | $-194M | $4M | $192M | $1M | $-107M |
| 2017 | $74M | $-8M | $240M | $-211M | $-136M | $-27M | |
| 2016 | $160M | $-257M | $51M | $-238M | $-78M | $-4M | |
| 2015 | $179M | $-238M | $122M | $-167M | $12M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net